The most prevalent Long Covid symptoms — crippling fatigue, post-exertional malaise and cognitive dysfunction—mirror those of ME/CFS and both are post-viral illnesses. We believe that learning more about Long Covid can deepen our understanding of ME/CFS, and that what we know about ME/CFS can shed light on Long Covid — and ultimately point to treatments and cures for both, as well as other long haul diseases that share their characteristics. To learn more about the connection between ME/CFS and Long Covid, visit our information center.
Solve M.E. embraces and supports many post-infectious chronic disease communities, such as: ME/CFS, Long Covid, Postural Orthostatic Tachycardia Syndrome (POTS), other forms of dysautonomia, Ehlers-Danlos Syndrome (EDS), Hypermobility Spectrum Disorder (HSD), and Mast Cell Activation Syndrome (MCAS). It has been our mission to increase federal funding dollars and research solutions that will make ME/CFS, Long COVID, and other Long Haul diseases more diagnosable, better understood, and treatable.
Our organization co-founded the Long COVID Alliance in February 2021, and expanded our advocacy efforts beyond ME/CFS to educate policymakers and accelerate research to address the emerging challenges facing those with ME/CFS, Long Covid and related “long haul” diseases. Solve M.E also opened our You + ME Registry & Biobank to include Long Covid and expanded our Ramsay Research Grant program to include the study of Long Covid. Both will help researchers track conditions similar to ME/CFS and other post-infectious diseases from onset, helping us to understand the effects of viral diseases on the immune system.